Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2012
06/07/2012US20120142109 Method for producing t cell population under presence of retinoic acid
06/07/2012US20120142108 Compositions For Treating Bacterial Infections
06/07/2012US20120142107 Method and system for somatic cell nuclear transfer
06/07/2012US20120142106 Method Of Forming Dendritic Cells From Embryonic Stem Cells
06/07/2012US20120142101 Oligonucleotide end caps
06/07/2012US20120142099 Novel bak binding protein, dna encoding the protein, and methods of use thereof
06/07/2012US20120142097 Fusion proteins of hiv regulatory/accessory proteins
06/07/2012US20120142096 Fusion proteins of hiv regulatory/accessory proteins
06/07/2012US20120142092 Rat embryonic stem cell
06/07/2012US20120142091 Antibodies Against Human Angiopoietin 2
06/07/2012US20120142090 Protein Expression System
06/07/2012US20120142079 Minicell based delivery of biologically active compounds
06/07/2012US20120142074 Compositions and Uses for an Alpha-Amylase Polypeptide of Bacillus Species 195
06/07/2012US20120142072 Soluble protein and utilization of the same
06/07/2012US20120142071 Thymidine Kinase Mutants
06/07/2012US20120142066 Metabolically Enhanced Photoautotrophic Ethanol Producing Host Cells, Method For Producing The Host Cells, Constructs For The Transformation Of The Host Cells, And Method Of Producing Ethanol Using The Host Cells
06/07/2012US20120142063 Nitrilase biocatalysts
06/07/2012US20120142062 Engineered cleavage half-domains
06/07/2012US20120142058 Conversion of Chitin into N-Acetylglucosamine, Glucosamine and Bioethanol
06/07/2012US20120142057 Method for production of polypeptide
06/07/2012US20120142056 MAMMALIAN EXPRESSION VECTOR pUHAB
06/07/2012US20120142054 Srsv detection kit
06/07/2012US20120142051 Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factor
06/07/2012US20120142050 Novel expression vector
06/07/2012US20120142049 Recombinant Gene Expression
06/07/2012US20120142048 Nucleic acid which is stabilized against decomposition
06/07/2012US20120142037 Glucose dehydrogenase
06/07/2012US20120142029 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
06/07/2012US20120142008 Methods for evaluating gastrointestinal absorption of chemicals
06/07/2012US20120142007 Stable compositions for nucleic acid amplification and sequencing
06/07/2012US20120142006 Massive parallel method for decoding dna and rna
06/07/2012US20120142000 Methods and compositions for assessment of pulmonary function and disorders
06/07/2012US20120141987 Method and probes for the detection of cancer
06/07/2012US20120141628 Method for the prevention or reduction of haze in beverages
06/07/2012US20120141573 Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Soluble Receptors and Uses Thereof
06/07/2012US20120141529 Norovirus and sapovirus antigens
06/07/2012US20120141525 Universal influenza vaccine based on recombinant modified vaccine ankara virus (mva)
06/07/2012US20120141522 Recombinant protective protein from streptococcus pneumoniae
06/07/2012US20120141517 Novel immunotherapy against several tumors including neuronal and brain tumors
06/07/2012US20120141515 Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE
06/07/2012US20120141511 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
06/07/2012US20120141505 Cd19-ligand and use
06/07/2012US20120141504 Methods for treating inflammation using b7-h4 polypeptides and fragments thereof
06/07/2012US20120141503 Heavy Chain and Domain Antibodies
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141493 Human binding molecules having killing activity against staphylococci and uses thereof
06/07/2012US20120141487 Moraxella catarrhalis antigens
06/07/2012US20120141486 Human monoclonal antibody
06/07/2012US20120141478 Compositions and methods for delivering anti-activated ras antibodies
06/07/2012US20120141466 Composition and method for treatment of reperfusion injury and tissue damage
06/07/2012US20120141462 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
06/07/2012US20120141460 Method for the production of variable domains
06/07/2012US20120141454 Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases
06/07/2012US20120141453 Glycosidase Enzymes
06/07/2012US20120141452 Targeted Therapeutic Proteins
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141441 Methods and Compositions for Treatment of Muscular Dystrophy
06/07/2012US20120141440 Foamyvirus vectors and methods of use
06/07/2012US20120141428 Muscle-derived cells (mdcs) for treating muscle- or bone-related injury or dysfunction
06/07/2012US20120141426 Reovirus for the Treatment of Cellular Proliferative Disorders
06/07/2012US20120141425 Virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition
06/07/2012US20120141422 Widespread gene delivery to the retina using systemic administration of aav vectors
06/07/2012US20120141419 Biodegradable Linkers for Molecular Therapies
06/07/2012US20120141418 Treatment of Melanoma Using HSV Mutant
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141413 Use of il-15 preparations to treat lymphopenia
06/07/2012US20120141376 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
06/07/2012CA2853171A1 Microbial production of polyhydroxyalkanoates
06/07/2012CA2821515A1 Anti-ngf compositions and use thereof
06/07/2012CA2820706A1 Optimized expression of glyphosate resistance encoding nucleic acid molecules in plant cells
06/07/2012CA2820622A1 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012CA2819944A1 Modified single-stranded polynucleotide
06/07/2012CA2819684A1 Stacked herbicide tolerance event 8264.44.06.1, related transgenic soybean lines, and detection thereof
06/07/2012CA2819669A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease
06/07/2012CA2819530A1 Cytotoxicity-inducing therapeutic agent
06/07/2012CA2819522A1 Method for cellular rna expression
06/07/2012CA2819491A1 Synthetic clonal reproduction through seeds
06/07/2012CA2819463A1 Tomm34 peptides and vaccines including the same
06/07/2012CA2819431A1 Targeted alteration of dna with oligonucleotides
06/07/2012CA2819423A1 Targeted alteration of dna
06/07/2012CA2819399A1 Marker for determination of sensitivity to triplet combination anti-cancer agent
06/07/2012CA2819356A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
06/07/2012CA2819253A1 Microbial production of natural sweeteners, diterpenoid steviol glycosides
06/07/2012CA2819222A1 Rational enzyme mining
06/07/2012CA2814595A1 Anticancer fusion protein
06/06/2012EP2460884A2 Process for preparing monatin
06/06/2012EP2460883A1 Method for producing l-amino acid
06/06/2012EP2460881A1 Proteoglycan degrading mutants for treatment of CNS
06/06/2012EP2460880A1 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells
06/06/2012EP2460878A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof
06/06/2012EP2460877A1 Modulation of CD133+ hematopoietic stem cells
06/06/2012EP2460873A1 A method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family with attenuated expression of any of the cynT, cynS, cynX or cynR genes or a combination thereof
06/06/2012EP2460872A1 Recombinant microorganisms for increased production of organic acids
06/06/2012EP2460871A1 Xylitol-producing strain to which an arabinose metabolic pathway is introduced, and method for producing xylitol using same
06/06/2012EP2460823A1 A modified secretion system to increase expression of polypeptides in bacteria
06/06/2012EP2460811A1 Improved modulators of coagulation factors
06/06/2012EP2460533A2 Yeast-based therapeutic for chronic hepatitis C infection
06/06/2012EP2460402A1 Method for gene transfer into triticum plant using agrobacterium bacterium, and method for production of transgenic plant of triticum plant
06/06/2012EP2459752A2 Enterococcus and fecal bacteroides for rapid water quality assessment
06/06/2012EP2459751A1 Method for determining the presence and concentration of analytes using a nucleic acid ligand and rare earth element
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 4023